コンテンツへスキップ
Merck
すべての画像(2)

主要文書

すべての文書を表示

53913-U

Supelco

Ascentis® Express 90 Å RP-Amide (2.7 μm) HPLC Columns

L × I.D. 10 cm × 2.1 mm, HPLC Column

別名:

コアシェル（SPP）融合コア極性埋め込み HPLC カラム

ログイン組織・契約価格を表示する
すべての画像(2)

About This Item

UNSPSCコード:
41115700
eCl@ss:
32110501
NACRES:
SB.52

製品名

Ascentis® Express RP-アミド, 2.7 μm HPLCカラム, 2.7 μm particle size, L × I.D. 10 cm × 2.1 mm

物質

stainless steel column

品質水準

100

認証

suitable for USP L60

製品種目

Ascentis®

特徴

endcapped

メーカー／製品名

Ascentis®

包装

1 ea of

パラメーター

60 °C temp. range
600 bar max. pressure (9000 psi)

テクニック

HPLC: suitable
LC/MS: suitable
UHPLC-MS: suitable
UHPLC: suitable

L × 内径

10 cm × 2.1 mm

表面積

135 m2/g

不純物

<5 ppm metals

Matrix

Fused-Core® particle platform
superficially porous particle

マトリックス活性基

amide, alkyl phase

粒径

2.7 μm

ポアサイズ

90 Å

動作pH範囲

2-9

アプリケーション

food and beverages

分離法

reversed phase

類似した製品をお探しですか？ 訪問 製品比較ガイド

関連するカテゴリー

アプリケーション

Ascentis® Express RP-Amide, 2.7 μmによる日焼け止めのUHPLC解析

法的情報

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany
Fused-Core is a registered trademark of Advanced Materials Technology, Inc.

アプリケーション

製品番号
詳細
価格

G005373

HPLCによる統合失調症治療薬の分析、Ascentis® Express RP-Amide, application for HPLC

G005668

LC/MS Analysis of Antipsychotic Drugs on Ascentis® Express RP Amide, application for HPLC

G005695

LC/MS Analysis of Drugs of Abuse on Ascentis® Express RP-Amide, application for HPLC

G005709

LC/MS Analysis of Methadone and Metabolites EDDP and EMDP on Ascentis® Express RP Amide, application for HPLC

G005714

HPLC Analysis of Organic Acids on Ascentis® Express RP-Amide, application for HPLC

G005723

LC/MS Analysis of Polypeptide Drugs on Ascentis® Express RP-Amide, application for HPLC

G005750

HPLC Analysis of CYP3A Inhibitors on Ascentis® Express RP-Amide, application for HPLC

ガードカートリッジ

製品番号
詳細
価格

必要ですが提供されていません

製品番号
詳細
価格

関連製品

製品番号
詳細
価格

保管分類コード

11 - Combustible Solids

WGK

WGK 3

引火点(°F)

Not applicable

引火点(℃)

Not applicable

最新バージョンのいずれかを選択してください：

試験成績書（COA）

Lot/Batch Number
USGN002781
USGN002779
USGN002777
USGN002776
USGN002775

適切なバージョンが見つかりませんか。

特定のバージョンが必要な場合は、ロット番号またはバッチ番号で特定の証明書を検索できます。

COAを検索

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

この製品を見ている人はこちらもチェック

Slide 1 of 4

1 of 4

Ascentis&#174; Express RP-アミド, 2.7 &#956;m HPLCカラム 2.7&#160;&#956;m particle size, L × I.D. 10&#160;cm × 3&#160;mm

Supelco

53918-U

Ascentis® Express RP-アミド, 2.7 μm HPLCカラム

Ascentis&#174; Express C18, 2.7 µm HPLCカラム 2.7&#160;&#956;m particle size, L × I.D. 10&#160;cm × 2.1&#160;mm

Supelco

53823-U

Ascentis® Express C18, 2.7 µm HPLCカラム

Ascentis&#174; Express C18, 2.7 µm HPLCカラム 2.7&#160;&#956;m particle size, L × I.D. 5&#160;cm × 2.1&#160;mm

Supelco

53822-U

Ascentis® Express C18, 2.7 µm HPLCカラム

Ascentis&#174;RP-Amide HPLCカラム 5&#160;&#956;m particle size, L × I.D. 25&#160;cm × 4.6&#160;mm

Supelco

565325-U

Ascentis®RP-Amide HPLCカラム

S Fan et al.
Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment, 30(12), 2093-2101 (2013-10-22)
A liquid chromatography-linear ion-trap spectrometry (LC-MS³) method using β-receptor molecular-imprinted polymer (MIP) solid-phase extraction (SPE) as clean-up was developed to determine simultaneously and confirmatively residues of 25 β₂-agonists and 21 β-blockers in urine samples. Urine samples were subjected to enzymatic
Michael T Furlong et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 926, 36-41 (2013-04-02)
Clopidogrel is prescribed for the treatment of Acute Coronary Syndrome and recent myocardial infarction, recent stroke, or established peripheral arterial disease. A sensitive and reliable high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay was developed and validated to enable reliable
Hirotaka Kushida et al.
Biomedical chromatography : BMC, 27(12), 1647-1656 (2013-07-03)
Uncaria Hook (UH) alkaloids are involved in the beneficial effects of Yokukansan. However, the pharmacokinetics of UH alkaloids after oral administration of Yokukansan has not yet been sufficiently investigated. Therefore, we developed and validated a sensitive and specific high-performance liquid
Fan Sai et al.
Journal of agricultural and food chemistry, 60(8), 1898-1905 (2012-02-15)
A sensitive method has been developed for the simultaneous determination of residues of 25 β₂-agonists and 23 β-blockers in animal foods by high-performance liquid chromatography coupled with linear ion trap mass spectrometry (HPLC-LIT-MS). This method is based on a new
Erzsébet Oláh et al.
Journal of chromatography. A, 1217(23), 3642-3653 (2010-04-23)
Today sub-2 microm packed columns are very popular to conduct fast chromatographic separations. The mass-transfer resistance depends on the particle size but some practical limits exist not to reach the theoretically expected plate height and mass-transfer resistance. Another approach applies
関連する文献をすべて表示

資料

Improving the Chromatographic Separation of DMB-Labeled Sialic Acids for the Comparison of Biosimilars to Reference Materials

A significantly improved HPLC-fluorescence method for DMB-NANA and -NGNA, and application of this method to compare 2 candidate biosimilar therapeutic proteins to their respective RMs.

Improving the Chromatographic Separation of DMB-Labeled Sialic Acids for the Comparison of Biosimilars to Reference Materials

A significantly improved HPLC-fluorescence method for DMB-NANA and -NGNA, and application of this method to compare 2 candidate biosimilar therapeutic proteins to their respective RMs.

Analysis of Pesticide Residues in Pistachios Using QuEChERS Extraction and Cleanup with Supel™ QuE Z-Sep+

Pistachios contain approximately 45% fat, which can result in a significant amount of coextracted matrix in the acetonitrile extract generated using the QuEChERS procedure. A zirconia based adsorbent significantly reduces coextracted matrix prior to LC-MS or GC-MS.

QuEChERS抽出とSupel™ QuE Z-Sep+によってクリーンアップしたピスタチオの残留農薬分析

ピスタチオの脂質含有率は約45%です。そのため、QuEChERSを適用して得られたアセトニトリル抽出物中には大量のマトリックスが共抽出されることがあります。ジルコニアベースの吸着剤は、LC-MSやGC-MSの前に共抽出されるマトリックスを大幅に減少させます。

すべて表示

プロトコル

HPLC Analysis of DMB-Labeled Sialic Acids on Ascentis® Express RP-Amide: Comparison of Biosimilars to Reference Materials

Separation of null

UHPLC/MS Analysis of Cannabinoids Extracted from Raw Cannabis Sativa (Marijuana) on Ascentis® Express RP-Amide

THC solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; Cannabidiolic acid solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material; Cannabichromene solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; Cannabigerolic acid solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material; Δ9-Tetrahydrocannabinolic acid A (THCA-A)

UHPLC/MS Analysis of Cannabinoids Extracted from Raw Cannabis Sativa (Marijuana) on Ascentis® Express RP-Amide

THC solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; Cannabidiolic acid solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material; Cannabichromene solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; Cannabigerolic acid solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material; Δ9-Tetrahydrocannabinolic acid A (THCA-A)

UHPLC/MS Analysis of Cannabinoids Extracted from Raw Cannabis Sativa (Marijuana) on Ascentis® Express RP-Amide

THC solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; Cannabidiolic acid solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material; Cannabichromene solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; Cannabigerolic acid solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material; Δ9-Tetrahydrocannabinolic acid A (THCA-A)

Chromatograms

application for HPLCapplication for HPLCapplication for HPLCapplication for HPLC表示を増やす

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら（テクニカルサービス）